Research and Markets: Streptococcus Pneumoniae Infection-Pipeline Insights - Strategically Significant Competitor Information, Analysis, and Insights to Formulate Effective R&D Development Strategies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/ztj5s3/streptococcus) has announced the addition of the "Streptococcus Pneumoniae Infection-Pipeline Insights" report to their offering.

This Streptococcus Pneumoniae Infection-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Streptococcus Pneumoniae Infection. This report provides information on the therapeutic development based on the Streptococcus Pneumoniae Infection dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies' information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Streptococcus Pneumoniae Infection
  • The report provides pipeline products under the drug profile section, which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Streptococcus Pneumoniae Infection pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Streptococcus Pneumoniae Infection and also provides company profiling
  • The report also gives information for dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages

Key Topics Covered:

  • Streptococcus Pneumoniae Infection Overview
  • Streptococcus Pneumoniae Infection Pipeline Therapeutics
  • Streptococcus Pneumoniae Infection Therapeutics under Development by Companies
  • Streptococcus Pneumoniae Infection Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Streptococcus Pneumoniae Infection Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Streptococcus Pneumoniae Infection Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Streptococcus Pneumoniae Infection Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Streptococcus Pneumoniae Infection - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Streptococcus Pneumoniae Infection - Discontinued Products
  • Streptococcus Pneumoniae Infection - Dormant Products
  • Companies Involved in Therapeutics Development for Streptococcus Pneumoniae Infection

For more information visit http://www.researchandmarkets.com/research/ztj5s3/streptococcus.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals